Study details
Enrolling now
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
Memorial Sloan Kettering Cancer Center
NCT IDNCT06130280ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
32
Study length
about 3.1 years
Ages
18+
Locations
7 sites in NJ, NY
What this study is about
This trial is testing if a single session of high-dose contrast-enhanced MRI-guided SBRT can prevent liver metastasis from growing and spreading. The researchers will also evaluate side effects and see if certain MRI image characteristics predict how well the treatment works.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive MR Guided Single Fraction Stereotactic Body Radiation Therapy (SBRT)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
radiation
Body systems
Gastroenterology, Oncology